Home Tags North America Analysis
North America Analysis Related Content
Morry Markowitz, President of the Fuel Cell and Hydrogen Energy Association, states the case for fuel cells to deliver reliable power when needed, therefore, enhancing emergency response efforts.
Helen Waters, Executive Vice President of MEDITECH explains how Alder Hey Children’s NHS Foundation Trust and South Tyneside and Sunderland NHS Foundation Trust are Global Digital Exemplars leading the UK’s healthcare revolution.
Peter G. Kevan, University Professor Emeritus at the School of Environmental Sciences, University of Guelph, explores here how plants regulate their body temperatures, including the implications in this respect for climate change science & policy.
APHIS, part of the USDA, is using a risk-based approach to protect U.S. agriculture from potentially devastating plant pests and diseases, as we discover here.
A very warm welcome to the October 2019 edition of North America Analysis, which boasts a vast array of mind transforming content on many policy issues from the region, including a special feature on advanced computing in the United States.
The Office of Conservation & Water coordinates the development of U.S. foreign policy on conserving and sustainably managing the world’s important ecosystems, as we find out here.
The role of the Canadian Institutes of Health Research, when it comes to funding health research in Canada, is explored here, including a look at the work of the Human Development, Child and Youth Health division within that.
Here, we explore the mission of the Directorate for Education and Human Resources at the National Science Foundation to achieve excellence in U.S. science, technology, engineering and mathematics (STEM) education at all levels.
Peter H. Santschi, Professor at Texas A&M University at Galveston, TX, shares his expert thoughts on the mobility of iodine species in the environment and solid waste.
Contributing scientists share their thoughts around the field of chemistry, focussing on enzyme activity assays for disease diagnosis, novel drug development validation and nanoparticles.
Benjamin Hsiao, Distinguished Professor from Stony Brook University provides an excellent overview of an aspect of chemistry that concerns sustainable water purification solutions from underutilised biomass.
Here, several experts from the International Society for Biological and Environmental Repositories provide a novel perspective around distributive biobanking models, including why biospecimens need blockchain.
Morry Markowitz, President of the Fuel Cell and Hydrogen Energy Association details all we need to know about the National Hydrogen and Fuel Cell Day on October 8th and beyond that.
Welcome to the July 2019 edition of North America Analysis, which features a wide range of insightful content on policy issues with a special focus on biology.
Welcome to the April 2019 edition of North America Analysis. One of the highlights in this issue is the special focus we have on neurodegenerative diseases, which includes comment from Jeffrey Borenstein, of the Brain & Behavior Research Foundation (BBRF).
Heading up this exciting North America Analysis, the National Eye Institute (NEI) takes stock of its progress in advancing vision research and developing new therapies to treat blinding diseases.
Welcome to this packed October 2018 edition of North America Analysis. Heading up this publication, we are honoured to include a piece from Michael F. Huerta from the National Library of Medicine at the U.S.’s National Institutes of Health. In his article, he explores how discovery and health benefit from the intersection of data science and open science
Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention
Developing genomic tools for increased thermotolerance in beef cattle is imperative, says University of Florida’s Associate Professor Raluca Mateescu
Welcome to the packed July 2018 edition of North America Analysis. One of the many insights in this edition comes from the Huntington’s Disease Society of America who explores the sources of funding in the development of therapies for Huntington’s disease (HD) in the U.S. today